MI Systemic lupus erythematosus (SLE) research has focused primarily on adaptive immunity. There is a growing body of literature implicating a role for dendritic cells (DCs) in many of the disease ...

July 10, 2024 — Scientists have discovered a molecular defect that promotes the pathologic immune response in systemic lupus erythematosus (known as lupus) and show that reversing this defect ...

Interferon-alpha activity may be used routinely in clinical settings as a biomarker for cutaneous lupus erythematosus and ...

A 23-year-old white woman with systemic lupus erythematosus (SLE ... cAPS was not thought to have a critical role in the pathogenesis of her coma. Medications were not thought to have induced ...

More than 50% of patients with systemic lupus erythematosus (SLE) develop lupus nephritis (LN) during the disease, which may ...

The odds of developing systemic lupus erythematosus or systemic sclerosis appear to significantly increase with the use of ...

Background SLE is a systemic autoimmune disease with a large number of common risk gene variants, but several rare gene ...

Long-term use of glucocorticoids (GCs) for the treatment of lupus is very common, however, it has also been associated with side effects like high blood pressure, diabetes, infection, and osteoporosis ...

Conduit Pharmaceuticals partners with Charles River to evaluate the efficacy of its lead programme in a pre-clinical lupus model, utilizing ...

Adicet Bio, Inc. (ACET), a clinical stage biotechnology company, Wednesday said it received Fast Track Designation from the U.S. Food ...

MI Systemic lupus erythematosus (SLE) research has focused primarily on adaptive immunity. There is a growing body of literature implicating a role for dendritic cells (DCs) in many of the disease ...